Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global ...
Cardamyst FDA approval and launch for PSVT, solid cash, and big expansion upside. Click for more on MIST stock.
North Shore University Hospital’s cardiology team became the first to complete a procedure using the novel OmniaSecure ...
After eight years of Labor, 2025 helped cement the ideological and policy shifts of the new government – headlined in 2025 by ...
Preliminary results from the FULCRUM-VT trial point to a safer, more effective way to treat ventricular tachycardia—a dangerous heart rhythm disorder that can lead to sudden cardiac arrest.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results